Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Cholesterol

Maternal Lipids at 28 Weeks’ Gestation and Offspring Adiposity at Age 5 to 7 Years

P. K. Thaware; S. McKenna; C. C. Patterson; C. Casey; D. R. McCance Maternal Lipids at 28 Weeks’ Gestation and Offspring Adiposity at Age 5 to 7 Years J Clin Endocrinol Metab
Cholesterol

Obesity and cardiovascular risk in an oncology day ward population

D. O'Reilly; L. Prior; L. Dooley; P. Calvert; M. O'Connor; A. Horgan; E. Jordan Obesity and cardiovascular risk in an oncology day ward population Ir J Med Sci
Cholesterol Insulin Resistance & Diabetes

Genes Involved in Oxidative Stress Pathways Are Differentially Expressed in Circulating Mononuclear Cells Derived From Obese Insulin-Resistant and Lean Insulin-Sensitive Individuals Following a Single Mixed-Meal Challenge

S. Baig; E. Parvaresh Rizi; C. Chia; M. Shabeer; N. Aung; T. P. Loh; F. Magkos; A. Vidal-Puig; R. C. S. Seet; C. M. Khoo; S. A. Toh Genes Involved in Oxidative Stress Pathways Are Differentially Expressed in Circulating Mononuclear Cells Derived From Obese Insulin-Resistant and Lean Insulin-Sensitive Individuals Following a Single Mixed-Meal Challenge Front Endocrinol (Lausanne)
Cholesterol Insulin Resistance & Diabetes

Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial

H. Risstad; T. T. Søvik; M. Engström; E. T. Aasheim; M. W. Fagerland; M. F. Olsén; J. A. Kristinsson; C. W. le Roux; T. Bøhmer; K. I. Birkeland; T. Mala; T. Olbers Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial JAMA Surg
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial

H. Risstad; J. A. Kristinsson; M. W. Fagerland; C. W. le Roux; K. I. Birkeland; H. L. Gulseth; P. M. Thorsby; R. P. Vincent; M. Engström; T. Olbers; T. Mala Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial Surg Obes Relat Dis
Cholesterol

Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery

G. J. Ooi; A. Earnest; L. Doyle; C. Laurie; J. M. Wentworth; K. Sikaris; C. W. le Roux; P. R. Burton; P. E. O’Brien; W. A. Brown Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery Obesity Surgery
Cholesterol Metabolic Syndrome

Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis

P. Mistry; V. Currie; P. Super; C. W. le Roux; A. A. Tahrani; R. Singhal Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis Clin Obes
Cholesterol Insulin Resistance & Diabetes Metabolic Syndrome

The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

M. A. Glaysher; J. Ward; M. Aldhwayan; A. Ruban; C. G. Prechtl; H. L. Fisk; N. Chhina; W. Al-Najim; C. Smith; N. Klimowska-Nassar; N. Johnson; E. Falaschetti; A. P. Goldstone; A. D. Miras; J. P. Byrne; P. C. Calder; J. P. Teare The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids Clin Nutr
Cholesterol

Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents

P. M. Ryan; E. Patterson; R. M. Kent; H. Stack; P. M. O'Connor; K. Murphy; V. L. Peterson; R. Mandal; D. S. Wishart; T. G. Dinan; J. F. Cryan; R. J. Seeley; C. Stanton; R. P. Ross Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents Sci Rep
Cholesterol

Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice

N. M. Pathak; P. J. B. Millar; V. Pathak; P. R. Flatt; V. A. Gault Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice Mol Cell Endocrinol
Cholesterol Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page4 Page5 Page6 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI